EcoDrugPlus

Ensembl ID : ENSMMDG00005001329
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSMMDG00005014252
Gene Symbol: -
Cross references: -
354 Possible Orthologues:

Ensembl ID : ENSMMDG00005012936
Gene Symbol: -
Cross references: -
164 Possible Orthologues:

Ensembl ID : ENSMMDG00005000615
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSMMDG00005003406
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSMMDG00005019675
Gene Symbol: -
Cross references: -
155 Possible Orthologues:

Ensembl ID : ENSMMDG00005004183
Gene Symbol: -
Cross references: -
80 Possible Orthologues:

Ensembl ID : ENSMMDG00005000221
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSMMDG00005004654
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSMMDG00005021131
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSMMDG00005014097
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSMMDG00005006309
Gene Symbol: -
Cross references: -
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).